Johnson & Johnson Completes Acquisition of Proteologix, Inc. for $850 Million

Johnson & Johnson  announced  that it has successfully completed the acquisition of Proteologix, Inc., a privately-held biotechnology compa...

June 24, 2024 | Monday | News
Roche Launches First Clinically Approved ISH Test for Comprehensive B-Cell Lymphoma Diagnosis

The VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay is the first clinically approved in-situ hybridisation (ISH) test with the sensitivity ...

June 20, 2024 | Thursday | News
Roche's Digital Pathology System Receives FDA Clearance for Clinical Diagnosis

The solution, which includes the VENTANA DP 200 slide scanner, Roche's digital pathology workflow software and a display, is now cl...

June 18, 2024 | Tuesday | News
Junshi Biosciences' Toripalimab Approved in China for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer

Shanghai Junshi Biosciences , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of nov...

June 18, 2024 | Tuesday | News
Myocene Raises €3 Million to Accelerate International Growth of Muscle Fatigue Measurement Device

Myocene, the Liège-based sportstech company developing a unique, cutting-edge device to objectively measure muscle fatigue,  announced that i...

June 18, 2024 | Tuesday | News
LIXTE Biotechnology Announces Clinical Trial Collaboration with Roche and NKI for MSI Low Metastatic Colon Cancer

LIXTE Biotechnology Holdings, Inc.  a clinical stage pharmaceutical company, today announced a collaboration with Roche and the Netherlands Cancer I...

June 17, 2024 | Monday | News
AbbVie and FutureGen Announce Strategic Partnership to Develop Next-Generation IBD Therapy

AbbVie  and FutureGen Biopharmaceutical (Beijing) Co., Ltd. announced a license agreement to develop FG-M701, a next generation TL1A antibody for th...

June 14, 2024 | Friday | News
Biosplice Therapeutics and Novo Nordisk Partner to Develop Innovative Diabetes Treatments Targeting DYRK Inhibition

  Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on smal...

June 13, 2024 | Thursday | News
Adcytherix Launches with €30 Million Seed Funding to Pioneer Next-Generation Antibody-Drug Conjugates for Cancer Treatment

Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team that founded and sold Emergence T...

June 11, 2024 | Tuesday | News
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients

NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, a...

June 11, 2024 | Tuesday | News
Asensus Surgical to be Acquired by KARL STORZ in $300 Million Deal

Asensus Surgical, , a global leader of innovative digital solutions for the operating room, today announced that it has entered into a definitive merger ...

June 10, 2024 | Monday | News
FDA Grants Emergency Use Authorization for Roche's Rapid PCR Test for SARS-CoV-2, Influenza A/B, and RSV

The test uses highly sensitive PCR technology, requiring only a single nasal-swab sample to provide rapid, accurate qualitative detection and different...

June 10, 2024 | Monday | News
QIAGEN Launches Enhanced QIAstat-Dx Respiratory Panel in Malaysia, Now Detects 23 Pathogens Including Chlamydophila pneumoniae

The CE-IVD marked QIAstat-Dx Respiratory SARS-CoV-2 Panel is available in Malaysia  expanded to 23 pathogens, now includes Chlamydophila pneumoniae&nb...

June 05, 2024 | Wednesday | News
ASP Japan Secures Exclusive Sales Contract with PENTAX Medical for Innovative Endoscopy Solutions

ASP Japan LLC (hereinafter referred to as ASP Japan) was announced by HOYA Group PENTAX Europe GmbH ( hereinafter referred to as PENTAX Medical) and the ...

May 31, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close